Photys Therapeutics Funding: $75M Raised, Series A (2022)
Photys Therapeutics is based in Waltham, MA. It has raised $75M in total funding. Latest round: Series A. Backed by MPM Capital, Omega Funds, Longwood Fund.
Photys Therapeutics funding overview
Photys Therapeutics is based in Waltham, MA. Photys Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2022. The round record for Photys Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include MPM Capital, Omega Funds, Longwood Fund, 8VC, Arkin Bio, Mass General Brigham Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Photys Therapeutics at a glance
Total raised
$75M
Latest round
Series A
Latest round date
September 2022
Headquarters
Waltham, MA
Notable investors
MPM Capital, Omega Funds, Longwood Fund, 8VC, Arkin Bio, Mass General Brigham Ventures, MRL Ventures Fund, Merck & Co.
Frequently asked about Photys Therapeutics funding
How much has Photys Therapeutics raised?
Photys Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Photys Therapeutics?
MPM Capital, Omega Funds, Longwood Fund, 8VC, Arkin Bio, Mass General Brigham Ventures are named among the investors backing Photys Therapeutics.
What was the latest Photys Therapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2022.
Where is Photys Therapeutics based?
Photys Therapeutics is based in Waltham, MA.
When did Photys Therapeutics last raise?
The last disclosed Photys Therapeutics round closed in September 2022 at Series A.
We update the Photys Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Waltham and their backers are listed below.
